Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2019
Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid TumorsKyung Hae Jung, Patricia LoRusso, Howard Burris, et al.Plos One|April 16, 2015
Frequency and characteristics of familial melanoma in Spain: the FAM-GEM-1 StudyIván Márquez-Rodas, Manuel Martín González, Eduardo Nagore, et al.Radiology|January 26, 2021
A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid TumorsMarta Ligero, Alonso Garcia-Ruiz, Cristina Viaplana, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2026
Combinatorial delivery of low-dose radiotherapy and immunotherapy to patients with immune-excluded tumors enhances CD8+ T cell functionalityMaria Ochoa-de-Olza, Nicolas Rayroux, Martina Imbimbo, et al.Immunity|September 14, 2024
Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanomaJohanna Chiffelle, David Barras, Rémy Pétremand, et al.Cancer Discovery|September 4, 2021
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to ImmunotherapyFernanda G Herrera, Catherine Ronet, Maria Ochoa de Olza, et al.Science Immunology|February 2, 2024
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8<sup>+</sup> T-myeloid cell networks in melanomaDavid Barras, Eleonora Ghisoni, Johanna Chiffelle, et al.Pageof 3